Recently, screening of 19 cancer TMAs with 2800 evaluable cancer cores confirmed that SORT1 is highly expressed in multiple tumors and may therefore be a promising target for the delivery and internalization of anticancer therapeutic agents (56, 57). The gene discussed is SORT1; the disease is cancer.